Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

822
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
822
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

949
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
949
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

318
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
318

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Drug-drug interactions with Mexidol in patients with ischemic stroke: Analysis of data from randomized clinical trials].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

Evaluation of the Effectiveness of Botulinum Therapy Based on the Anthropometric Characteristics of the Face Using Non-Invasive Thermal Imaging Data.

Diagnostics (Basel, Switzerland)·2025
Same author

[Features of care of patients with cardiovascular diseases and cognitive disorders].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Herbal extracts in hepatoprotection: antioxidant and immunomodulatory effects. A review].

Terapevticheskii arkhiv·2024
Same author

[Management of patients with insomnia and polymorbidity. A draft of the clinical guidelines].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2024
Same author

The Pterygomandibular Space: A Volumetric Evaluation Using the Novel A-Silicone Injections Method.

Diagnostics (Basel, Switzerland)·2024
Same journal

[Impairment of retinal and choroidal blood flow autoregulation in preeclampsia].

Vestnik oftalmologii·2026
Same journal

[Non-glaucomatous optic nerve atrophy: epidemiology, etiological structure, and clinical diagnostic features].

Vestnik oftalmologii·2026
Same journal

[Microbiota and microbiome of the lacrimal drainage system].

Vestnik oftalmologii·2026
Same journal

[Differential assessment of diagnostic signs of primary open-angle glaucoma and high myopia].

Vestnik oftalmologii·2026
Same journal

[Applied anatomy of the optic nerve].

Vestnik oftalmologii·2026
Same journal

[Epidemiology and diagnostic methods of microbial keratitis].

Vestnik oftalmologii·2026
See all related articles

Related Experiment Video

Updated: Nov 16, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

5.5K

[Drug-induced uveitis].

O D Ostroumova1,2, E V Chikh1, E V Rebrova1

  • 1I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

Vestnik Oftalmologii
|February 21, 2021
PubMed
Summary
This summary is machine-generated.

Drug-induced uveitis is a growing concern, linked to new medications like biological agents and antivirals. Early detection and treatment of this inflammatory eye condition are crucial for effective symptom management.

Keywords:
adverse drug reactionsdrug-induced uveitisuveitis

More Related Videos

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

2.9K
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.5K

Related Experiment Videos

Last Updated: Nov 16, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

5.5K
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

2.9K
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.5K

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Immunology

Background:

  • Medicinal products are increasingly recognized as potential risk factors for ocular diseases.
  • Drug-induced uveitis is a significant and growing cause of ocular inflammation.

Purpose of the Study:

  • To highlight the increasing prevalence of drug-induced uveitis.
  • To discuss the association of new drug classes with uveitis.
  • To emphasize the importance of timely diagnosis and management.

Main Methods:

  • Review of recent literature on drug-induced uveitis.
  • Analysis of common symptoms and clinical presentations.
  • Discussion of diagnostic criteria and treatment strategies.

Main Results:

  • Newer drug classes, including biological agents (immune checkpoint inhibitors, BRAF/MEK inhibitors, VEGF/TNF-α inhibitors), systemic bisphosphonates, and antivirals, are associated with increased drug-induced uveitis.
  • Symptoms manifest days to months after drug initiation and include eye pain, photophobia, floaters, and vision loss.
  • Inflammatory changes in the retina and optic nerve are common outcomes.

Conclusions:

  • Prompt drug cessation and anti-inflammatory therapy are key to managing drug-induced uveitis.
  • Understanding the pathogenesis, diagnosis, and treatment of drug-induced uveitis is clinically relevant.
  • Increased awareness of drug-induced uveitis is necessary for ophthalmologists and prescribing physicians.